IPP Bureau
Iktos and Zealand Pharma to develop AI technology for peptide drug design
By IPP Bureau - June 22, 2022
Agreement to co-develop artificial intelligence (AI) technology for the application in peptide drug design
Cortexyme announces preclinical data demonstrating efficacy of COR803 for Covid infections
By IPP Bureau - June 22, 2022
COR803 is a novel small molecule 3CLpro inhibitor discovered and developed by Cortexyme based on its expertise in cysteine protease inhibition.
Apollo Hospitals becomes first in the APAC to bag three HIMSS Stage 6 certifications
By IPP Bureau - June 21, 2022
It is only the second healthcare provider in the world to attain the Stage 6 DIAM certification.
Indira IVF inaugurates new centre in Delhi Patel Nagar
By IPP Bureau - June 21, 2022
Indira IVF has established technological supremacy as the key differentiator, delivering industry leading success rate
Cadila Pharma launches formulation development lab
By IPP Bureau - June 21, 2022
The ground floor of the formulation development laboratory is focused on solid orals, the first floor on injections, and the second floor houses the analytical lab
Medix Biochemica acquires Bioresource Technology
By IPP Bureau - June 21, 2022
Bioresource Technology's state of the art manufacturing facility in Weston, Florida
Parexel expands patient access to clinical trials through new community alliance network
By IPP Bureau - June 21, 2022
Alliances with CVS Health and Javara further embed clinical research into the community healthcare setting, expanding access to patient populations across the U.S to increase diversity in clinical trials
India welcomes TRIPS waiver deal at WTO
By IPP Bureau - June 21, 2022
TRIPS waiver for five years agreed in the recently concluded WTO will help countries manufacture COVID vaccines to deal with the pandemic
Unilever, Genomatica form venture to develop palm oil based alternatives
By IPP Bureau - June 20, 2022
With $120m jointly invested in the newly-formed initiative, and with other strategic investors expected to join, the venture will develop an alternative, plant-based ingredient using biotechnology
Cipla signs agreement for acquisition of 21.05% stake in Achira Labs
By IPP Bureau - June 20, 2022
This investment will facilitate a Cipla entity's strategic participation in the Poe diagnostics and AMR space through the design, development, and manufacturing of microfluidics-based technologies
Aurobindo Pharma board approves acquisition of GLS Pharma
By IPP Bureau - June 20, 2022
The company has a total sales of Rs. 25.8 crore during FY 21-22 and Rs. 26.4 crore during FY 20-21.
Polio Sub-National Immunization Day to be conducted from 19th June 2022
By IPP Bureau - June 20, 2022
The states where Polio vaccine drops will be conducted includes: Bihar, Chandigarh, Delhi, Gujarat, Haryana, Jharkhand, Maharashtra, Punjab, Rajasthan, Uttarakhand, and West Bengal
Aether Industries Q4 FY22 revenue up 26.8%; Profit up 13.8%
By IPP Bureau - June 18, 2022
Revenues from operations for the full year ended March 31, 2022 stood at Rs. 590.05 crore as compared to Rs. 449.82 crore in FY21
Stelis Biopharma’s two biologics manufacturing facilities receive EU cGMP accreditation
By IPP Bureau - June 18, 2022
Both manufacturing facilities are based out of Benguluru, India
Revelation Pharma completes 8th acquisition
By IPP Bureau - June 17, 2022
Wedgewood Pharmacy operates compounding pharmacies that offers sterile and non-sterile compounded medications for animal patients in 50 states.
